Johnson & Johnson 

€0
42062
+€0+0% Today

Statistics

Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
0
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

14AprExpected
Q4 2025
Next
2.11
2.17
2.22
2.28
Expected EPS
2.2831767088
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow JNJ.MU. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap161.09B
Pfizer competes directly with JNJ in the pharmaceuticals sector, offering a wide range of prescription drugs and vaccines.
Merck
MRK
Mkt Cap298.84B
Merck operates in the pharmaceutical industry, directly competing with JNJ in areas such as vaccines and prescription medications.
Abbvie
ABBV
Mkt Cap369.39B
AbbVie, a research-based biopharmaceutical company, competes with JNJ in multiple therapeutic areas, including immunology and oncology.
Novartis
NVS
Mkt Cap297.32B
Novartis competes with JNJ in the healthcare sector, particularly in pharmaceuticals, offering drugs in areas like oncology and neurology.
Roche
RHHBY
Mkt Cap321.08B
Roche Holding AG competes in the pharmaceutical and diagnostics sectors, areas where JNJ is also a key player.
Bristol-Myers Squibb
BMY
Mkt Cap121.69B
Bristol Myers Squibb is a competitor in the pharmaceutical industry, offering prescription drugs in areas like cancer and cardiovascular diseases, similar to JNJ.
GSK
GSK
Mkt Cap113.29B
GlaxoSmithKline competes with JNJ in pharmaceuticals and consumer healthcare products, including vaccines and over-the-counter medicines.
Sanofi
SNY
Mkt Cap116.63B
Sanofi competes with JNJ in the pharmaceutical sector, particularly in areas like vaccines, rare diseases, and multiple sclerosis treatments.
AMGEN
AMGN
Mkt Cap187.56B
Amgen, a biopharmaceutical company, competes with JNJ in the development of innovative therapies, particularly in oncology and cardiology.
Abbott Laboratories
ABT
Mkt Cap178.76B
Abbott Laboratories competes with JNJ in the medical devices and diagnostics sectors, as well as in nutritional products and generic pharmaceuticals.

About

Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the AVEENO, CLEAN & CLEAR, DR. CI:LABO, NEUTROGENA, and OGX brands; TYLENOL acetaminophen products; SUDAFED cold, flu, and allergy products; BENADRYL and ZYRTEC allergy products; MOTRIN IB ibuprofen products; NICORETTE smoking cessation products; and PEPCID acid reflux products. It also offers STAYFREE and CAREFREE sanitary pads; o.b. tampons; adhesive bandages under the BAND-AID brand; and first aid products under the NEOSPORIN brand. It serves general public, retail outlets, and distributors. The company's Pharmaceutical segment offers products for rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; HIV/AIDS and COVID-19 infectious diseases; mood disorders, neurodegenerative disorders, and schizophrenia; prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; thrombosis, diabetes and macular degeneration; and pulmonary arterial hypertension. This segment serves retailers, wholesalers, distributors, hospitals, and healthcare professionals directly for prescription use. Its MedTech segment provides electrophysiology products to treat cardiovascular diseases; neurovascular care products to treat hemorrhagic and ischemic stroke; orthopaedics products in support of hips, knees, trauma, spine, sports, and other; advanced and general surgery solutions that focus on breast aesthetics, ear, nose, and throat procedures; and disposable contact lenses and ophthalmic products related to cataract and laser refractive surgery under the ACUVUE brand. This segment serves wholesalers, hospitals, and retailers. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Show more...
CEO
Mr. Joaquin Duato
Employees
141700
Country
United States
ISIN
US4781601046

Listings

0 Comments

Share your thoughts

FAQ

What is Johnson & Johnson stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on exchange Johnson & Johnson stocks are traded under the ticker JNJ.MU.
When is the next Johnson & Johnson earnings date?
Johnson & Johnson is going to release the next earnings report on April 14, 2026.
What were Johnson & Johnson earnings last quarter?
JNJ.MU earnings for the last quarter are 2.11 EUR per share, whereas the estimation was 2.11 EUR resulting in a -0.12% surprise. The estimated earnings for the next quarter are N/A EUR per share.
How many employees does Johnson & Johnson have?
As of April 12, 2026, the company has 141,700 employees.
In which sector is Johnson & Johnson located?
Johnson & Johnson operates in the Health & Wellness sector.
When did Johnson & Johnson complete a stock split?
Johnson & Johnson has not had any recent stock splits.
Where is Johnson & Johnson headquartered?
Johnson & Johnson is headquartered in New Brunswick, United States.